4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-009380
SVP, Chief Technical Officer acquired 8,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LaBarre Michael J. · SVP, Chief Technical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-12 | Exercise or conversion : show line 1 in the form | +8,050 | $13.10 | $105,455 | 156,846 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-10-12 | Exercise or conversion : show line 2 in the form Option to Purchase Common Stock | −8,050 | $13.10 | 2024-02-06 | 8,050 | 0 | D |
Loading xslF345X03/edgar.xml…